VALIDITY EXPIRED personal data approved: 2009. III. 25. Publications |
2008
manual entry, 2009. III. 25. |
Müller J, KRALOVÁNSZKY J, Adleff V, Pap E, Németh K, Komlósi V, Kovács G.: Toxic encephalopathy and delayed MTX clearance after high-dose methotrexate therapy in a child homozygous for the MTHFR C677T polymorphism., Anticancer Res, pp. 3051-3054 type of document: Journal paper/Article impact factor: 1.497 language: English URL |
2007
manual entry, 2009. III. 24. |
KRALOVÁNSZKY J., Adleff V., Hitre E., Pap É., Réti A., Komlósi V., Budai B.: Farmakogenetikai vizsgálatok a fluoropirimidint tartalmazó adjuváns kezelés hatékonyságának és toxicitásának előrejelzésére colorectális daganatokban., Magyar Onkológia, pp. 113-125 type of document: Journal paper/Article language: Hungarian URL |
2005
manual entry, 2009. III. 24. |
Hitre E., Budai B., Adleff V., Czeglédi F., Horváth Zs., Gyergyay F., Lövey J., Kovács T., Orosz Zs., Láng I., Kásler M., KRALOVÁNSZKY J.: Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil., Pharmacogenetics and Genomics,, pp. 723-730 type of document: Journal paper/Article impact factor: 6.406 number of independent citations: 13 language: English URL |
2005
manual entry, 2009. III. 24. |
Jeney A, Kralovánszky J: Onkofarmakológia, Medicina kiadó, pp. 1-941 type of document: Book/Monography number of independent citations: 8 language: Hungarian
|
2004
manual entry, 2009. III. 24. |
Adleff V., Hitre E., Köves I., Orosz Zs., Hajnal A., KRALOVÁNSZKY J.: Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in hungarian colorectal cancer patients., Int J Cancer, pp. 852-856 type of document: Journal paper/Article impact factor: 4.416 number of independent citations: 16 language: English URL |
2002
manual entry, 2009. III. 24. |
KRALOVÁNSZKY J., Köves I., Orosz Zs., Katona Cs., Tóth K., Rahóty P., Czeglédi F., Kovács T., Budai B., Hullán L., Jeney A.: Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors., Oncology, pp. 167-174 type of document: Journal paper/Article impact factor: 2.330 number of independent citations: 24 language: English URL |
1999
manual entry, 2009. III. 24. |
KRALOVÁNSZKY J., Katona Cs., Jeney A., Pandi E., Noordhuis P., Erdélyi-Tóth V., Kovács P., Van der Wilt CL, Peters GJ:: 5-ethyl-2'deoxyuridine, a modulator of both anti-tumor action and pharmacokinetics of 5-fluorouracil., J.Cancer Res. Clin. Oncol., pp. 675-684 type of document: Journal paper/Article impact factor: 1.052 number of independent citations: 3 language: English URL |
1998
manual entry, 2009. III. 24. |
Katona Cs., KRALOVÁNSZKY J., Rosta A., Pandi E., Fónyad G.,Tóth K.,Jeney A: The putative role of dihydropyrimidine dehydrogenase in the toxic side effect of 5-Fluorouracil, Oncology, pp. 468-475 type of document: Journal paper/Article impact factor: 2.858 number of independent citations: 31 language: English Full text |
1997
manual entry, 2009. III. 24. |
Codacci-Pisanelli G, KRALOVÁNSZKY J, Van der Wilt CL, Noordhuis P, Colofiore JR, Martin DS, Frandri F, Peters GJ:: Modulation of 5-fluorouracil in mice using uridine diphosphoglucose, Clinical Cancer Research, pp. 309-315 type of document: Journal paper/Article impact factor: 3.419 number of independent citations: 3 language: English Full text |
| Number of independent citations to these publications: | 98 |
|
|